Yoshikatsu Koga - Concepedia

Author

Yoshikatsu Koga

National Cancer Center Hospital East ORCID

Also Known As

Y Koga, Y. Koga, YOSHIKATSU KOGA, Yoshikatsu Koga

142

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

National Cancer Center Hospital East Kumamoto University University of Tsukuba The University of Tokyo NanoCarrier (Japan)

About

Yoshikatsu Koga is an author at National Cancer Center Hospital East specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	666
2	Engineering	3	3	200
3	Biomedical Engineering	2	2	59
4	Allergy	1	1	23
5	Biomolecular Engineering	1	1	141

Yoshikatsu Koga

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening Yoshikatsu Koga, Masahiro Yasunaga, Amane Takahashi, Cancer Prevention Research ImmunologyGastroenterologyPathologyExtracellular MicrovesiclesExfoliated Colonocytes	2010	220
Exosome can prevent RNase from degrading microRNA in feces. Yoshikatsu Koga, Masahiro Yasunaga, Yoshihiro Moriya, PubMed	2011	178
Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer Jooyeon Ahn, Yutaka Miura, Naoki Yamada, Biomaterials NanomedicineDrug TargetingEngineeringPancreatic CancerPolymer-drug Conjugate	2014	141
<scp>NC</scp>‐6300, an epirubicin‐incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin Amane Takahashi, Yoshiyuki Yamamoto, Masahiro Yasunaga, Cancer Science Molecular PharmacologyMedicinal ChemistryMicellar StructureAnti-inflammatoryPolymer-drug Conjugate	2013	117
U3-1402, a Novel HER3-Targeting Antibody–Drug Conjugate, for the Treatment of Colorectal Cancer Shigehiro Koganemaru, Yasutoshi Kuboki, Yoshikatsu Koga, Molecular Cancer Therapeutics	2019	95
Fecal miR-106a Is a Useful Marker for Colorectal Cancer Patients with False-Negative Results in Immunochemical Fecal Occult Blood Test Yoshikatsu Koga, Nobuyoshi Yamazaki, Yoshiyuki Yamamoto, Cancer Epidemiology Biomarkers & Prevention	2013	83
Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factor Ryo Tsumura, Shino Manabe, Hiroki Takashima, Journal of Controlled Release	2018	73
Potent antitumor effect of SN‐38‐incorporating polymeric micelle, NK012, against malignant glioma Jun‐ichiro Kuroda, Jun‐ichi Kuratsu, Masahiro Yasunaga, International Journal of Cancer	2008	67
Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts Yoshikatsu Koga, Shino Manabe, Yoshiyuki Aihara, International Journal of Cancer Pancreatic CancerMedicineTumor GrowthImmunologyPharmacology	2015	66
High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer Nobuyoshi Yamazaki, Yoshikatsu Koga, Hirokazu Taniguchi, Oncotarget	2016	50

Page 1